Friday's Small-Cap Winners & Losers
Inspire Pharma (ISPH) gained on word it will take over commercializing InSite Vision's (ISV) eye-infection drug, AzaSite, in the U.S. and Canada. Inspire shares were rising 38 cents, or 5.2%, to $7.75.
LookSmart (LOOK) shares were sliding on soft guidance. The Internet search-engine operator said 2007 revenue will grow by 20% to 25% from 2006's top line of $48.8 million, meaning a range between $58.6 million and $61 million. Two analysts are seeking sales of $70.2 million. Fourth-quarter revenue, at $15 million, was slightly under the $15.5 million target. Shares were down 90 cents, or 16.7%, to $4.48.
Canada's Westaim (WEDX) was plunging after the firm -- which owns companies dealing in flat-panel display products, wound-care products and pharmaceuticals -- widened its losses from continuing operations and saw slightly lower revenue than it did last year. Shares were sinking 20 cents, or 15.9%, to $1.06.
Sonic Solutions (SNIC) was lower after the business-software company said it will need to restate downward its prior financials for "material" noncash stock-option charges. It can't yet provide any monetary specifics. The Novato, Calif., company also said revenue for the quarter ended Dec. 31 totaled $39.1 million, which barely misses the $40.9 million mean projection. Shares were down $1.96, or 12.2%, to $14.07.Pacificnet (PACT) sank on word of management changes. Joseph Levinson, who was appointed chief financial officer less than six months ago, is being replaced by Daniel Lui, formerly of KPMG and PricewaterhouseCoopers. The China-based communications-technology company was slumping by 43 cents, or 6.6%, to $6.12.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV